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Ultrasound (US) has a significant role in diagnostic breast imaging. It is most commonly used as an adjunctive test in characterizing
lesions detected by other imaging modalities or by clinical examination. US is recognized as the modality of choice in the evaluation of
women who are symptomatic and younger than 30 years of age, pregnant, or lactating. Combined mammography and US appear to have
a role in screening high-risk populations. The use of standard Breast Imaging Reporting and Data System US lexicon is helpful in guiding the
differentiation between benign and malignant sonographic signs. Biopsy is warranted when benign features are absent or for any feature
consistent with malignancy, despite other benign findings. Whole breast and axillary US are useful in assessing tumour extension, multi-
focality, and the status of axillary lymph nodes. US is the modality of choice for guiding interventional breast procedures. The role of US as
a guidance tool for nonoperative breast treatment is being investigated.Re´sume´
L’e´chographie joue un roˆle important dans l’imagerie diagnostique des seins. Elle est souvent utilise´e comme examen d’appoint afin de
caracte´riser les le´sions de´cele´es par d’autres techniques d’imagerie ou lors d’un examen clinique. Elle est reconnue comme la technique de
choix pour l’e´valuation des femmes qui pre´sentent des symptoˆmes et qui ont moins de 30 ans, qui sont enceintes ou qui allaitent. La
combinaison de la mammographie et de l’e´chographie semble pouvoir jouer un roˆle dans le de´pistage de la maladie chez les groupes a` risque
e´leve´. L’usage du lexique de l’e´chographie mammaire normalise´ selon le Breast Imaging Reporting and Data System permet de diffe´rencier
les signes de tumeurs malignes et be´nignes a` l’e´chographie. La biopsie est justifie´e en cas d’absence de caracte´ristiques propres aux tumeurs
be´nignes ou de pre´sence de toute caracte´ristique associe´e a` la malignite´, meˆme si d’autres signes indiquent la be´nignite´. L’e´chographie
mammaire et de la re´gion axillaire aide a` e´valuer l’e´tendue tumorale, sa nature multifocale et l’e´tat des nœuds lymphatiques axillaires.
L’e´chographie est la me´thode a` privile´gier pour orienter les techniques interventionnelles dans la re´gion des seins. On e´tudie actuellement le
roˆle qu’elle pourrait jouer dans l’orientation des traitements de nature non chirurgicale dans cette meˆme re´gion.
 2011 Canadian Association of Radiologists. All rights reserved.
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Breast biopsyIntroduction
With improvement of technique, ultrasound (US) plays
a significant role in breast imaging as a diagnostic tool when
further investigating abnormalities seen on other imaging
modalities or in patients with symptoms. Combined
mammography and US appear to have a role in screening
high-risk populations. This article will describe the current
status of the use of breast US in both diagnostic and
screening settings.* Address for correspondence: Anat Kornecki, MD, FRCPC, Department
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The sonographic examination of breast tissue presents
several technical challenges. Breast tissue is heterogeneous,
with curved interfaces that result in reflection, scattering, and
defocusing of the incident beam. The US system used also
must be capable of detecting superficial, deep, and retro-
areolar lesions. For these reasons, high-resolution, real-time
linear arrays, with a centre frequency of at least 10 MHz or
higher and the capability of electronic focal zone adjustment
are recommended for standard use. The standard breast US
field of view should reach the chest wall but not beyond
(Figure 1). Because fat is the most hypoechoic structure of
normal breast tissue, it serves as the reference against which
the echogenicity of breast lesions are compared.ll rights reserved.
Figure 2. Sagittal sonographic image, showing complex cystic mass with
solid component and wall thickening. A 78-year-old woman presented with
a palpable lump. Pathology results showed invasive ductal carcinoma, not
otherwise specified.
Figure 1. Transverse sonographic image of normal breast tissue. Pre-, intra-,
and retromammary fat appears as the most hypoechoic structure.
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Breast Imaging Reporting and Data System (BI-RADS)
lexicon initially was used only in mammography. In an
attempt to standardize the description and reporting of breast
lesions in all modalities, the American College of Radiology
published, in 2003, an extended version of the 3rd edition,
which includes new sections on breast US and magnetic
resonance imaging (MRI) [1]. The breast US descriptors are
based on shape, orientation, margin, boundary, echo pattern,
posterior acoustic features, and surrounding tissue, as well as
special features, such as intramammary lymph nodes. Hong
et al [2] assessed the use of BI-RADS lexicon descriptors
in correlation with pathology results. The sonographic
descriptors of mass margin, shape, orientation, lesion
boundary, echo pattern, and posterior acoustic features were
significantly different for malignant and benign masses. The
researcher concluded that the sonographic BI-RADS lexicon
was useful in differentiating between benign and malignant
solid masses.
The BI-RADS lexicon requires the breast imaging report
be summarized into 1 of 7 possible categories: BI-RADS 0,
further assessment required; BI-RADS 1, negative study; BI-
RADS 2, benign finding (risk of malignancy similar to that
of the surrounding parenchyma); BI-RADS 3, probably
benign finding (less than 2% risk of malignancies should be
followed up at 6, 12, and 24 months, and then classified as
benign category 2 after showing stability for 24 months or
biopsied if concerning changes or growth are seen); BI-
RADS 4, lesion is suspicious for malignancy (biopsy is
offered); BI-RADS 5 lesions are highly suggestive of
malignancy; and BI-RADS 6 lesions are biopsy-proven
malignant before surgery is obtained (it is suggested that
appropriate actions should be taken for these categories).
Distinguishing Benign Masses from Malignant Lesions
Originally, breast US was used to distinguish cysts from
solid masses that then were usually further assessed with
biopsy. With improved equipment and techniques, it is now
possible, in a large number of cases, to distinguish benign
from malignant features of cystic and solid lesions, and thus
reduce the number of unnecessary biopsies. Occasionally,
there are pathognomonic sonographic characteristics that
suggest a specific diagnosis (such as in the case of an
intramammary node) that will not require further
management.Evaluation of CystsBreast cysts are categorized as simple, complicated, or
complex. Simple cysts are anechoic, well-circumscribed,
round or ovoid masses with thin walls and increased
through transmission of sound. They are considered benign
(BI-RADS 2) and do not require intervention. Painful cysts
can be aspirated.
Complicated cysts contain low-level internal echoes or
debris that may layer and shift with changes in patient
position. The risk of malignancy among complicated breast
cysts is less than 2%, and they can be managed as BI-RADS
3 category and be followed up. If a complicated cyst is
symptomatic or enlarging, then needle aspiration is
suggested [3,4].
Complex breast cysts are defined as cysts with thick walls
and/or thick septations (>0.5 mm), intracystic masses, or
other discrete solid components (Figure 2). A Doppler study
may demonstrate intramural blood flow, which is indicative
of a solid component to the cyst. Because complex cysts are
associated with a greater than 2% risk of malignancy, they
require a biopsy [3,5]. Uncertainty regarding the nature of
a breast mass should be resolved with the performance of
US-guided aspiration or core biopsy.
A cluster of microcysts (usually composed of cysts that
measure between 1e7 mm, with less than 0.5-mm thickness
of intervening septations) is a relatively common incidental
finding and represents the dilatation of the acini of the
terminal duct lobular unit. Berg [6] reported that, in the
absence of a solid component, clustered microcysts are likely
benign and could be followed up annually.Evaluation of Solid LesionsSolid lesions are classified as benign, indeterminate, or
malignant. In 1995, Stavros et al [7] reported sonographic
criteria that classified solid lesions as benign, indeterminate,
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and, in addition, manifest one or more of the following
benign features: (1) intense uniform hyperechogenicity (in
comparison with the fat); (2) wider than tall orientation (long
axis parallel to the chest wall), with thin, echogenic capsule;
and (3) gentle lobulations (not more than 3), with thin,
echogenic capsule. If any of the following characteristics
were present, marked hypoechogenicity, spiculated contour,
taller-than-wide orientation (long axis not parallel to the
chest wall), angular margins, posterior acoustic shadowing,
punctate calcifications, duct extension, branch pattern, or
microlobulations, then the mass was classified as malignant.
A mass with neither benign nor malignant characteristics was
classified as indeterminate. All lesions were biopsied. Of 424
lesions that were prospectively classified as benign based on
the above criteria, only 2 were found to be malignant at
biopsy (negative predictive value of 99.5%). Of the 125
lesions found to be malignant at biopsy, 123 were classified
as malignant or indeterminate (positive predictive value of
98.4%). The researchers concluded that lesions that appear
benign on US based on the suggested criteria can be followed
up because they have less than 1% rate of malignancy.
Further biopsy is required if a lesion is classified as inde-
terminate or malignant. Similar results are reported by other
studies [8,9]. It is important to realize that, even if the overall
appearance of a lesion favors a benign entity, the presence of
a single malignant feature necessitates biopsy (Figure 3).
Before discounting the possibility of a malignant lesion,
the current mammographic study should be compared with
all previous mammograms. An apparently new or progress-
ing solid lesion on mammogram should undergo biopsy
regardless of benign features, whereas stability in the
appearance of a lesion with benign features over a period of
at least 2 years may not require follow-up [10]. Multiplicity
of benign-appearing lesions, especially if bilateral,Figure 3. Radian sonographic image, showing a hypoechoic mass that is
wider than tall, with microlobulated borders, and no evidence of echogenic
capsule. A 62-year-old woman who was called back for the assessment of an
abnormality seen on screening mammogram. Pathology results confirmed
invasive ductal carcinoma, not otherwise specified.contributes to the level of confidence in a probably benign
assessment [11]. In women with known breast cancer, biopsy
should be considered for a benign-appearing solid mass [11].
The sonographic criteria for benign solid lesions have
traditionally been used only for nonpalpable lesions. Graf et
al [12] investigated 152 patients with palpable breast lesions
that exhibited benign features. These patients were either
monitored for disease progression for at least 2 years or
underwent biopsy of the lesion. They concluded that the
sonographic criteria indicative of a benign lesion when
applied to nonpalpable breast masses could also be applied to
palpable solid lesions. Such masses should be managed as
BI-RADS 3 category lesions. Shin et al [13] suggested
a similar approach.
Sonographic Appearance of Common Breast LesionsFibroadenomaFibroadenoma is the most common solid lesion of the
breast. Approximately 30% present with typical benign
sonographic characteristics and can be followed up (Figure
4) [14]. Multiple fibroadenomas can be seen in 15% of
patients with fibroadenoma. There is substantial overlap in
the sonographic characteristics of fibroadenoma and phyl-
lodes tumours. In contrast with a benign fibroadenoma,
a phyllodes tumour may grow rapidly and can be either
benign or malignant. Phyllodes tumour usually require wide
surgical excision if tumour recurrence is to be avoided. An
enlarging fibroadenoma on follow-up, therefore, should be
biopsied to exclude the possibility of phyllodes tumour [15].Fat NecrosisFat necrosis of the breast is a common, benign, inflam-
matory process that usually results from an injury. OnFigure 4. Transverse sonographic image, showing an oval shape, isoechoic
mass with thin, echogenic capsule. A 52-year-old woman underwent short-
term follow-up. Biopsy was offered because of interval growth and proved
fibroadenoma.
34 A. Kornecki / Canadian Association of Radiologists Journal 62 (2011) 31e40imaging studies, the appearance of fat necrosis varies from
typically benign to suggestive of malignancy. The patho-
physiology of fat necrosis explains its imaging spectrum
from hemorrhage at early stage through inflammation,
necrosis, and peripheral fibrosis followed by scarring and
calcifications. Mammography is superior to US at demon-
strating the fat component as low density compared with the
fibroglandular tissue. US findings can often be misleading,
with a range of appearances that include benign and malig-
nant characteristics. Correlation of a suggestive clinical
history with a benign mammographic image may avert
biopsy in a large number of cases (Figure 5) [16]. In patients
with a history of breast cancer, fat necrosis should be care-
fully differentiated from tumour recurrence. Biopsy is
required when there is uncertainty.PapillomaPapilloma is a benign ductal neoplasm usually located at
the retroareolar region. The most common presentation on
US is of an intraductal mass. Internal duct flow may be
present and permit the clinician to distinguish a papilloma
from intraductal debris. Current literature indicates excision,
even if the lesion is benign on core biopsy. Localization for
surgical excision can be offered without core biopsy if the
appearance is sonographically typical (Figure 6) [17].Radial ScarRadial scar is considered to be a benign lesion, which
histopathologically resembles tubular carcinoma and is
believed by many to be a precursor for breast cancer. It
requires surgical excision for definite diagnosis. The
sonographic features of radial scar include mainlyFigure 5. Transverse sonographic image, showing heterogeneous mass with irr
reduction, presented with painful left breast (A). Mediolateral oblique mammogr
finding (arrow). Surgery was performed because of symptoms, and pathology codiminished echogenicity and parenchymal distortion
(Figure 7). It is not uncommon for radial scar to be seen on
US and not on a mammogram. There are no specific US
features that accurately distinguish radial scar from
malignant lesions [18].Inflammatory Breast DiseaseInflammatory breast disease comprises infectious, nonin-
fectious, and malignant etiologies. The presence of an ill-
defined fluid collection on US favors a benign condition,
such as mastitis; whereas extensive skin thickening and
axillary lymphadenopathy favors malignancy, such as
inflammatory breast cancer or lymphoma (Figure 8) [19].
Clinical correlation is required, and aspiration can be
obtained for both treatment and diagnosis. Lactation is
a common cause of mastitis and abscess formation. US is
useful in facilitating the diagnosis and guiding aspiration of
collections, with a maximum diameter of less than 3 cm [20].
When an inflammatory breast cancer is suspected, punch
skin biopsy is usually required to prove invasion into dermal
lymphatics.Ductal Carcinoma In SituMammography is the modality of choice in the evaluation
of ductal carcinoma in situ (DCIS). US may be beneficial in
the assessment of DCIS that presents without calcifications
or in the evaluation of the extent of disease in women with
dense breasts. Large clusters of microcalcifications can be
visualized and biopsied under US, especially when
stereotactic-guided biopsy is not possible. Dilated ducts with
indistinct borders are the most common US findings in DCISegular posterior shadowing. A 61-year-old patient with a history of breast
aphic image (B), showing a lucent lesion, which correlates to the ultrasound
nfirmed fat necrosis.
Figure 8. Anti-radian sonographic image, demonstrating marked skin
thickening along the medial aspect of the left breast. A 52-year-old patient
presented with skin oedema. Biopsy results revealed primary breast
lymphoma.
Figure 6. Transverse sonographic image, showing an intraductal echogenic
mass. A 46-year-old woman presented with nipple discharge. Excisional
biopsy proved benign intraductal papilloma.
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when a solid component is present [21].
The Role of US in Treatment Planning, Surgery, and
Post-treatment Follow-up
Preoperative whole-breast US has proven to be beneficial
in establishing the extent of unilateral (multifocality, same
quadrant; or multicentricity, different quadrants) and bilat-
eral disease. This may influence the type and extent of
surgical intervention [22]. This is particularly important
when lesions are mammographically occult, such as with
lobular carcinoma [23], and assessment with MRI is not
possible. Moon et al [24] reported preoperative bilateral
whole-breast US found new malignant multifocal, multi-
centric, or contralateral disease not detected by mammog-
raphy or by examination in 18% of patients (Figure 10).Figure 7. Transverse Doppler image, showing a hypoechoic area with
marked distortion and increased blood flow. A 24-year-old woman presented
with a palpable lump. Pathology results proved radial scar.Most patients with invasive breast cancer without clini-
cally suspicious lymph nodes are undergoing sentinel lymph
node assessment to exclude metastatic involvement. Results
of several studies have shown that preoperative axillary US
and fine-needle aspiration (FNA) cytology or core biopsy can
reduce the number of the more time-consuming sentinel
lymph node evaluation and second surgeries [25]. Lymph
node with cortical thickening of 2e3 mm appears to be
a threshold beyond which US-guided biopsy should be
offered (Figure 11) [26,27]. US of the parasternal region is
helpful in the assessment of the status of the internal
mammary lymph nodes. Metastatic internal mammary nodes
from breast origin can be found in about 20% of cases and
are usually located in the anterior upper 4 intercostals spaces
and measure more than 6 mm [28].Figure 9. Transverse sonographic image, showing dilated irregular ducts
within the retroareolar region. A 46-year-old woman presented with palpable
lump. Pathology results proved high-grade ductal carcinoma in situ.
Figure 10. Transverse ultrasound (US) images. (A and B) Images showing lesions that were also detected on mammogram. Transverse sonographic image,
showing a third lesion discovered on subsequent whole-breast US when using a different US machine (C). A 72-year-old woman presented with a palpable
lump on the left breast. Pathology results proved invasive ductal carcinomas with prominent lobular features in all 3 lesions.
Figure 11. Sagittal ultrasound image, showing an axillary node with cortical
thickening of more than 3 mm. A 54-year-old patient with known breast
cancer. Biopsy results proved breast malignancy involvement of lymphoid
tissue.
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(LABC) (stage III) requires a combined treatment approach
that involves surgery, radiation, and systemic therapy. Neo-
adjuvant chemotherapy before surgery is now the common
treatment approach. MRI has a major role in staging of these
cancers. US plays a role in identifying patients with LABC
and allows monitoring of their response to neoadjuvant
chemotherapy, especially when MRI is not possible (Figure
12) [29]. US has a significant role in the postoperative
assessment of patients with breast cancer. It is helpful in
evaluating postoperative recurrent breast masses and post-
surgical complications, such as seroma, infection, and fat
necrosis, as well as exclusion of recurrent disease (Figure
13).
US-guided Interventional Procedures
Sonographically guided 14-gauge automated core biopsy
was first described by Parker et al [30] in 1993. The
researchers reported 100% concordance between the diag-
noses obtained by core biopsy and surgical excision of
lesions in the 49 patients who underwent both. Furthermore,
in 132 who underwent biopsy and follow-up, no cancers
occurred in the 12e36-month period of monitoring. It is
recommended that, when possible, core biopsy will be
obtained under sonographic guidance because of patient
comfort, efficiency, low cost, absence of ionizing radiation,
and real-time visualization of the needle and target. The useof FNA biopsy of solid lesions has been reported by several
researchers to be inferior to core biopsy in terms of diag-
nostic accuracy [31,32]. FNA biopsy is still appropriate for
the investigation of cystic lesions. When FNA of a complex
cystic mass is performed and a solid component remains
visible at US, core-needle biopsy of the residual solid lesion
should be performed immediately after the aspiration
Figure 12. Sagittal sonographic image, showing extensive hypoechoic mass
with skin invasion (short arrow) and microcalcifications (long arrows). A 28-
year-old lactating patient presented with a palpable lump. Biopsy specimen
results revealed high-grade invasive ductal carcinoma, not otherwise speci-
fied. The patient was treated with neoadjuvant therapy with good response.
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a malignancy [5].
Other US-guided biopsy devices, such as vacuum-assisted
devices, have been developed; however, they have not been
proven to yield a significant difference in outcome compared
with core biopsy device [33,34]. The pathology results from
biopsy should be compared with imaging findings to deter-
mine concordance, and the conclusion should be communi-
cated to the referring physician (Figure 14) [35]. When
performing a biopsy or aspiration of a small lesion, it is
important to leave a radiopaque marker that can be identified
subsequently. Also, after treatment with neoadjuvant
chemotherapy, in particular, if lumpectomy is contemplated,
then a marker should be placed because the lesion may
become occult [36].Figure 13. Sagittal sonographic image, showing irregular, hypoechoic mass
located at the region of the lumpectomy scar (arrow). A 64-year-old woman
underwent left lumpectomy 4 years before the current study. Ultrasound was
obtained in addition to mammogram as part of her routine surveillance.
Pathology showed invasive cancer with histologic features similar to her
primary disease, which indicated recurrence.Axillary nodes can be sampled by using FNA or core
biopsy. Biopsy of lymph nodes should be targeted to the
cortex. The hilum should be avoided to reduce the risk of
bleeding [37,38]. Lesions that are diagnosed by imaging and
that require surgery are usually localized before surgery by
using wire and/or injection of methylene blue. This can be
performed by using US guidance if the lesion is reasonably
well seen on US.
Breast lesion management has evolved towards a mini-
mally invasive approach [39]. The next challenge is to treat
benign and malignant breast lesions without surgery. Several
new minimally invasive procedures, including radio-
frequency ablation, interstitial laser ablation, focused US
ablation, cryotherapy, and vacuum-assisted devices are
currently under investigation and may provide treatment
options that are comparable with that of traditional surgical
therapies [40e44].
Targeted US for MRI-detected Breast Lesions
With the increased use of MRI in breast imaging, there is
often a need to further evaluate lesions detected on MRI.
MRI-guided procedures are very expensive. US is a common
adjunct modality in identification, characterization, and
biopsy of lesions detected by MRI. Destounis et al [45]
reported that targeted US of MRI-detected breast abnor-
mality changed management in 20% (36 of 182) of patients
(Figure 15).
Male Breast
The male breast is primarily composed of fatty tissue,
with few branching ducts and connective tissue. Lobules areFigure 14. Anti-radian sonographic image, showing hypoechoic mass with
irregular borders. A 26-year-old woman with a strong family history of
breast cancer, presented with a palpable lump. The lesion was reported as
BI-RADS 5. Initial biopsy specimen results were normal. Surgical excision
was recommended because of discordance. Pathology results proved inva-
sive ductal carcinoma, not otherwise specified.
Figure 15. (A) Postcontrast axial T1-weighted magnetic resonance image (MRI), showing an abnormal enhancing lesion located within the left upper outer
quadrant. A 54-year-old patient found to have metastatic adenocarcinoma that involved the left axillary node of unknown origin. Mammogram and ultrasound
(US) were obtained first and revealed no abnormalities. (B) Anti-radian sonographic image of a second-look US, showing a crescent-shape hypoechoic area in
the region that correlates to the MRI finding. Pathology revealed invasive ductal carcinoma, not otherwise specified.
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reason that lobular carcinoma and fibroadenoma are rare in
men. The breast tissue in men may respond to hormonal
stimulation, with growth of ducts and connective tissue that
results in gynecomastia. The typical mammographic
appearance of gynecomastia usually confirms the diagnosis.
The sonographic appearance of gynecomastia is of a fairly
symmetric star-shaped mass that arises directly from the
retroareolar surface without causing any overlying skin
thickening or nipple retraction. Breast cancer in men
resembles that seen in woman clinically and sonographically,
and should be managed in a similar way. Fibroadenoma and
cystic masses are rare in men, therefore, any discrete breast
masses should be biopsied unless they appear typically
benign (Figure 16) [46,47].
Advanced US Technology
Routine breast US uses B-mode grey-scale imaging.
Harmonic, compound, and Doppler imaging can also be used
to help characterize lesions. New technical developments,
such as breast elastography, three-dimensional (3D) US, andFigure 16. Bilateral sagittal sonographic images, revealing bilateral symmetric
roareolar masses. Transverse sonographic image, demonstrating a retroareolar irre
with Paget disease of the nipple.computer-aided diagnosis (CAD), are now available on some
machines.3D Breast USThe 3D US images are reconstructed from a single sweep
of the US beam across the lesion of interest. 3D US, there-
fore, can evaluate the entire surface and volume of the mass.
The utility of this technology was evaluated by Cho et al [48]
who compared the ability to characterize masses by using 2-
dimensional versus 3D static US images. Their conclusion
was that there are no significant differences in the perfor-
mance of radiologists in characterization of solid breast
masses when using 1 technique versus the other.US ElastographyElastography is a dynamic technique that uses US to
provide an estimation of viscoelastic properties of tissue by
measuring the degree of distortion upon the application of an
external force. The diagnostic value of using US elastog-
raphy to differentiate benign from malignant breast lesionsgynecomastia. (A) A 14-year-old boy presented with bilateral palpable ret-
gular mass that contains microcalcifications (arrows). (B) A 71-year-old man
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Itoh et al [49] reported the outcome of the use of conven-
tional US and real-time US elastography of 111 lesions (59
benign, 52 malignant). They showed that elastography had
86.5% sensitivity, 89.8% specificity, and 88.3% accuracy in
detection of malignant lesions, whereas conventional US had
71.2% sensitivity, 96.6% specificity, and 84.7% accuracy.
Their conclusion was that US elastography had almost
the same diagnostic performance as conventional US. The
researchers expect that with future improvements in the
technology, this modality will become a valuable tool in
the diagnosis of breast disease.Breast US CADSonographic images of the breast can be analysed on aCAD
module based on shape,margin, texture, and posterior acoustic
characteristics. The CAD software allows automatic reporting
by using the BI-RADS lexicon. Gruszauskas et al [50] inves-
tigated the ability of the US CAD in differentiating benign
from malignant lesions among 508 patients and found that the
sensitivity of the use of CAD was high but that the specificity
was relatively low. Their conclusion was that further studies
are required to assess this technique [50].Contrast USAngiogenesis present in malignant breast masses provides
the pathophysiologic basis for the use of contrast media in
US. Rapid contrast uptake and rapid washout distinguishes
benign from malignant lesions. Contrast US imaging uses
injection of microbubbles during real-time imaging. The role
of contrast breast US is still being investigated. Ricci et al
[51] showed that contrast US seems to be a reliable method
to differentiate breast lesions, because it provides typical
enhancement patterns and perfusion curves correlate well
with MRI wash inewash out curves.
Screening US
Although mammography is an effective screening
modality, it is less sensitive in detecting cancer in dense
breast tissue. Breast US has limitations as a potential
screening tool because it requires a well-trained skilled
operator, the techniques are not standardized, and breast US
may not detect microcalcifications. There are insufficient
data on the use of screening US in the general population.
Some studies reported reasonable results when using US
breast screening, but most data are available from diagnostic
populations and screening studies limited to women with
dense breasts and increased risk for breast cancer. The results
among these groups show that US may detect about 4
additional breast cancers per 1000 women, but there is higher
false-positive rate by adding US than with mammography
alone [52e54]. It is well accepted among researchers that US
should only be used as an adjunctive test to mammography
and should not be used alone. Combined mammography andbreast US surveillance maybe an option for those who refuse
or cannot have breast MRI.
Several companies have developed automated US systems
that enable fast scanning of the entire breast. A larger field of
view is obtained with these systems compared with that
generated with a hand-held US transducer, and they are used
as an adjunct to mammography. Kelly et al [55] report breast
cancer detection in 6425 studies when using automated US
with mammography, doubled from 3.6 per 1000 with
mammography alone to 7.2 per 1000. They also showed that
the number of detected invasive cancers, measuring 10 mm
or less, tripled, from 7 to 21, when automated breast US
supplemented mammography. Specificity based on recalls
was 89.9% for automated US, 95.15% for mammography,
and 98.7% for combined mammography and automated US.
Summary
Breast US is a very important modality in the assessment of
breast cancer. It plays a major role as a diagnostic tool in the
enhanced characterization of lesions detected by other
imaging modalities or in symptomatic patients but should
always be used as an adjunctive tool to mammography in
patients older than 30 years, unless the patient is pregnant or
lactating. Combined mammography and US have a role in
screening high-risk patients. The use of BI-RADS US lexicon
is helpful in distinguishing benign from malignant features,
and unnecessary biopsy can be avoided in a significant number
of cases. Biopsy is always required when 1 or more malignant
features are present, even if a lesion appears benign. Whole-
breast and axillary US are recommended in evaluating the
extension of malignancy and lymph node involvement. Breast
lesions and axillary lymph nodes can be safely and accurately
biopsied under US guidance. Discordance between pathology
results and imaging results should be communicated to the
clinicians. The role of US as a guidance tool in nonoperative
treatment is being investigated. Elastography, 3D, CAD US,
and automated whole-breast screening US are techniques that
may have an impact on future clinical performance.
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